Global Thyroid Hormone Test Market Growth (Status and Outlook) 2024-2030

A thyroid hormone test is a medical diagnostic test used to measure the levels of thyroid hormones in the blood. The thyroid gland, located in the neck, produces hormones that play a crucial role in regulating metabolism, growth, and energy expenditure in the body.

The global Thyroid Hormone Test market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Thyroid Hormone Test Industry Forecast” looks at past sales and reviews total world Thyroid Hormone Test sales in 2022, providing a comprehensive analysis by region and market sector of projected Thyroid Hormone Test sales for 2023 through 2029.

This Insight Report provides a comprehensive analysis of the global Thyroid Hormone Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Thyroid Hormone Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Thyroid Hormone Test market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Thyroid Hormone Test and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Thyroid Hormone Test.

United States market for Thyroid Hormone Test is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Thyroid Hormone Test is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Thyroid Hormone Test is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Thyroid Hormone Test players cover:

• Quest Diagnostics Incorporated
• Laboratory Corporation of America Holdings
• Ulta Lab Tests, LLC
• DHA Laboratory
• Everly Health, Inc.

In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Thyroid Hormone Test market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Thyroid-Stimulating Hormone (TSH)
• Thyroxine (T4)
• Triiodothyronine (T3)

Segmentation by Application:

• Hospitals
• Diagnostic Laboratories
• Clinics
• Research Laboratories & Institutes

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration:

• Quest Diagnostics Incorporated
• Laboratory Corporation of America Holdings
• Ulta Lab Tests, LLC
• DHA Laboratory
• Everly Health, Inc.
• ZRT Laboratory LLC
• Danaher Corporation
• Thyrocare Technologies Limited
• Siemens Healthineers AG
• Abbott Laboratories